Eagle Pharmaceuticals Culture Company

Dr. Adrian Hepner, MD, Ph.D. has been Chief Medical Officer and Executive Vice President at Eagle Pharmaceuticals Inc., since January 2016. Dr. Hepner served as Executive Vice President of Clinical Research, Medical and Regulatory Affairs at Eagle Pharmaceuticals Inc. from January 2015 to January 2016. He served as Vice President of Clinical Research and Medical Affairs at BioDelivery Sciences International, Inc. since October 2014. He served as Vice President of Clinical Research & Regulatory Affairs at BioDelivery Sciences International, Inc. from July 23, 2013 to October 2014. He served as Senior Medical Director at UCB BioSciences, Inc., where he was responsible for global development projects in the central nervous system therapeutic area. Dr. Hepner served as Vice President of Clinical Research at Avanir Pharmaceuticals, Inc. Dr. Hepner is involved in filing of multiple INDs and NDAs. He has over 20 years of U.S. and international experience in clinical studies. He served as a Clinical Consultant to a number of pharmaceutical companies. He joined Avanir Pharmaceuticals, Inc. in 2006 as Senior Director of Clinical Research. In 2001, he joined IVAX Research, where he served as Director of New Drug Development. He served as Director of Innovative R&D at TEVA Pharmaceuticals. He has over 30 published papers and has also received an award from the National Academy of Medicine in Argentina for his research work in dementias. Dr. Hepner trained first as a Physician and later as a Neuropsychiatrist at the University of Buenos Aires School of Medicine. He spent a number of years as a Post-doctoral Fellow in neuro psychopharmacology at the University of Ottawa. He was a Leading Clinical Investigator in Latin America.

Mr. Steven L. Krill, Ph.D. has been the Chief Scientific Officer at Eagle Pharmaceuticals Inc. since February 2013 and also serves as its Executive Vice President. Mr. Krill served as Vice President of Pharmaceutical Development at Eagle Pharmaceuticals from October 2011 to February 2013. Dr. Krill served as the Vice President of Scientific Affairs at Teva Parenteral Medicines from March 2009 to August 2011. Dr. Krill held the positions of Vice President Pharmaceutical Research and Development (since December 2005 until March 2009) and Director of Pharmaceutics and Investigational Supplies (from May 2002 to December 2005) at Boehringer Ingelheim. Prior to that, Dr. Krill held various management positions at Lipocine Inc., Novartis Pharmaceuticals and Abbott Laboratories Dr. Krill is an author of over 30 publications and inventor of multiple patents in the area of drug delivery. Dr. Krill holds a B.S. in pharmacy and an M.S. in pharmaceutical sciences from the University of Cincinnati and a Ph.D. in Pharmaceutics from the University of Utah.